Patrick Loehrer is an Oncology physician affiliated with Indiana University Health. OpenAlex indexes 545 publications with 26,270 citations (h-index 80); ClinicalTrials.gov lists 9 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
535 Barnhill Dr
Rt 448
Indianapolis, IN 462025116
Telephone
317-278-7418Provider last certified this registry record 25 Mar 2025.
Clinical trials
- Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
Sponsor: Patrick Joseph Loehrer Sr.
- A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Sponsor: Patrick Joseph Loehrer Sr.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.8%Atypical Antipsychotic19.4%Olanzapine100%Part D<11 patientsOpioid Agonist10.7%Oxycodone Hcl100%Part D<11 patients+ 1 more class in this area
Sensory organs
23.3%Corticosteroid23.3%Dexamethasone100%Part D<11 patientsMetabolism & gastrointestinal
21.4%Antidiarrheal microorganisms21.4%Creon100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1985–2024 per NIH RePORTER. The latest:
- The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
Indiana University Indianapolis
FY2024$926,411U54CA254518 - The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
Indiana University Indianapolis
FY2023$923,799U54CA254518
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Zipes, MD
Indiana University Health
Lawrence Einhorn, MD
Indiana University Health
Lisa Landrum, MD
Indiana University Health
Benjamin Gaston, MD
Indiana University Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”